CD14 and breast cancer: Additionally, in Figures 2E, F, the IVW method demonstrated that genetically predicted CD14+ CD16+ monocytes were also associated with an increased risk of BC (OR = 1.000, 95% CI: 1.000–1.001, p = 0.005).